BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16814065)

  • 21. Effect of low and passive flow on OVD thermal properties during phacoemulsification.
    Ungricht EL; Harris JT; Jensen NR; Barlow WR; Murri MS; Olson RJ; Pettey JH
    Can J Ophthalmol; 2023 Dec; 58(6):507-512. PubMed ID: 35868436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free radicals in phacoemulsification and aspiration procedures.
    Takahashi H; Sakamoto A; Takahashi R; Ohmura T; Shimmura S; Ohara K
    Arch Ophthalmol; 2002 Oct; 120(10):1348-52. PubMed ID: 12365914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding, retaining, and removing dispersive and pseudodispersive ophthalmic viscosurgical devices.
    Arshinoff SA; Wong E
    J Cataract Refract Surg; 2003 Dec; 29(12):2318-23. PubMed ID: 14709292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retention of silicone oil droplets from ophthalmic viscosurgical devices in the drainage angle of 2 eyes.
    Lam PT; Cheng AC; Rao S; Lam DS
    J Cataract Refract Surg; 2007 Nov; 33(11):1994-6. PubMed ID: 17964414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silicone oil content in ophthalmic viscosurgical devices.
    Ohrstrom A; Svensson B; Tegenfeldt S; Celiker C; Lignell B
    J Cataract Refract Surg; 2004 Jun; 30(6):1278-80. PubMed ID: 15177604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new histological evaluation method to detect residual ophthalmic viscosurgical devices for cataract surgery.
    Mori H; Yamada H; Toyama K; Takahashi K
    Heliyon; 2018 Sep; 4(9):e00822. PubMed ID: 30272034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of the soft-shell technique using Viscoat and Hyal-2000.
    Kim H; Joo CK
    J Cataract Refract Surg; 2004 Nov; 30(11):2366-70. PubMed ID: 15519090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rotational stability of a single-piece hydrophobic acrylic intraocular lens during removal of ophthalmic viscosurgical devices.
    Hyon JY; Yeo HE
    Am J Ophthalmol; 2010 Feb; 149(2):253-257.e1. PubMed ID: 19896633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical results of phacoemulsification with the use of Healon5 or Viscoat.
    Tetz MR; Holzer MP; Lundberg K; Auffarth GU; Burk RO; Kruse FE
    J Cataract Refract Surg; 2001 Mar; 27(3):416-20. PubMed ID: 11255054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of viscoelastic substances used in cataract surgery on corneal metabolism and endothelial morphology: comparison of Healon and Viscoat.
    Maár N; Graebe A; Schild G; Stur M; Amon M
    J Cataract Refract Surg; 2001 Nov; 27(11):1756-61. PubMed ID: 11709248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective randomized comparison of DisCoVisc and Healon5 in phacoemulsification and intraocular lens implantation.
    Oshika T; Bissen-Miyajima H; Fujita Y; Hayashi K; Mano T; Miyata K; Sugita T; Taira Y
    Eye (Lond); 2010 Aug; 24(8):1376-81. PubMed ID: 20395973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of unknown intraocular material after cataract surgery: evaluation of a potential cause of toxic anterior segment syndrome.
    Mathys KC; Cohen KL; Bagnell CR
    J Cataract Refract Surg; 2008 Mar; 34(3):465-9. PubMed ID: 18299073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-compartment technique to remove ophthalmic viscosurgical devices.
    Tetz MR; Holzer MP
    J Cataract Refract Surg; 2000 May; 26(5):641-3. PubMed ID: 10831891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical Safety Evaluation of Ophthalmic Viscosurgical Devices in Rabbits and a Novel Mini-Pig Model.
    Leang RS; Kloft LJ; Gray B; Gwon AE; Huang LC
    Ophthalmol Ther; 2019 Mar; 8(1):101-114. PubMed ID: 30778776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rheological and Adhesive Properties to Identify Cohesive and Dispersive Ophthalmic Viscosurgical Devices.
    Watanabe I; Hoshi H; Sato M; Suzuki K
    Chem Pharm Bull (Tokyo); 2019; 67(3):277-283. PubMed ID: 30828005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the corneal endothelial protective effects of Healon-D and Viscoat.
    Peck CM; Joos ZP; Zaugg BE; Abdel-Aziz S; Stringham JD; Werner L; Mamalis N; Olson RJ
    Clin Exp Ophthalmol; 2009 May; 37(4):397-401. PubMed ID: 19594567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dispersive viscosurgical devices demonstrate greater efficacy in protecting corneal endothelium in vitro.
    Yildirim TM; Auffarth GU; Son HS; Khoramnia R; Munro DJ; Merz PR
    BMJ Open Ophthalmol; 2019; 4(1):e000227. PubMed ID: 30997401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DisCoVisc versus the soft-shell technique using Viscoat and Provisc in phacoemulsification: randomized clinical trial.
    Praveen MR; Koul A; Vasavada AR; Pandita D; Dixit NV; Dahodwala FF
    J Cataract Refract Surg; 2008 Jul; 34(7):1145-51. PubMed ID: 18571083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular pressure after bilateral cataract surgery using Healon, Healon5, and Healon GV.
    Arshinoff SA; Albiani DA; Taylor-Laporte J
    J Cataract Refract Surg; 2002 Apr; 28(4):617-25. PubMed ID: 11955901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Healon5 and 4 other viscoelastic substances on intraocular pressure and endothelium after cataract surgery.
    Holzer MP; Tetz MR; Auffarth GU; Welt R; Völcker HE
    J Cataract Refract Surg; 2001 Feb; 27(2):213-8. PubMed ID: 11226784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.